Armistice Capital’s Celgene Corp CELG Stock Holding History

Armistice Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-512,000	Closed	-$50.8M	–	98
2019 Q3	$50.8M	Buy	512,000 +112,000	+28%	+$10.6M	3.37%	4
2019 Q2	$37M	Sell	400,000 -192,000	-32%	-$18.2M	2.33%	12
2019 Q1	$55.8M	Buy	+592,000	New	+$51.8M	3.06%	5
2018 Q3	–	Sell	-175,000	Closed	-$13.9M	–	98
2018 Q2	$13.9M	Buy	+175,000	New	+$14.5M	0.91%	36

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Armistice Capital's CELG Position: Q4 2019 in Review

Armistice Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 512,000 shares — an estimated $50.8M sold.

Armistice Capital first reported a position in CELG in Q2 2018 and held it in 4 quarters. The position peaked at $55.8M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Armistice Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Armistice Capital sold 512,000 Celgene Corp shares in Q4 2019, an estimated $50.8M.
Armistice Capital first reported a position in Celgene Corp in Q2 2018 and held it in 4 quarters.
Armistice Capital's Celgene Corp position peaked at $55.8M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Armistice Capital's 13F filing for Q4 2019, filed 14 Feb 2020.